Critical Insights From Clarivate Analyst Ratings: What You Need To Know
Clarivate (NYSE:CLVT) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 1 | 1 | 2 | 1 | 0 |
Last 30D | 1 | 0 | 0 | 0 | 0 |
1M Ago | 0 | 0 | 0 | 0 | 0 |
2M Ago | 0 | 0 | 0 | 0 | 0 |
3M Ago | 0 | 1 | 2 | 1 | 0 |
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $7.9, with a high estimate of $10.00 and a low estimate of $6.00. Highlighting a 13.19% decrease, the current average has fallen from the previous average price target of $9.10.
Breaking Down Analyst Ratings: A Detailed Examination
The standing of Clarivate among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
George Tong | Goldman Sachs | Lowers | Buy | $7.50 | $8.50 |
Toni Kaplan | Morgan Stanley | Lowers | Equal-Weight | $8.00 | $9.00 |
Manav Patnaik | Barclays | Lowers | Underweight | $6.00 | $7.00 |
Ashish Sabadra | RBC Capital | Lowers | Sector Perform | $8.00 | $10.00 |
Owen Lau | Oppenheimer | Lowers | Outperform | $10.00 | $11.00 |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Clarivate. This information provides a snapshot of ...
Full story available on Benzinga.com